| Nombre del producto |
D(minus)-norgestrel |
| Sinónimos |
Levonorgestrel; Norgestrel (L-); 13-ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one; 13-ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one; 13-ethyl-17-hydroxy-19-dinor-17-alpha-pregn-4-en-20-yn-3-on(+)-1; 17-alpha-ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one; 17-beta-hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one; 17-ethynyl-18-methyl-19-nortestosteron; 17-ethynyl-18-methyl-19-nortestosterone; 18-methyl-17-alpha-ethynyl-19-nortestosterone; (14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) |
| Fórmula molecular |
C21H28O2 |
| Peso Molecular |
312.45 |
| InChI |
InChI=1/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16?,17?,18?,19-,20?,21-/m0/s1 |
| Número de registro CAS |
797-63-7 |
| EINECS |
212-349-8 |
| Estructura Molecular |
|
| Densidad |
1.13g/cm3 |
| Punto de fusión |
206℃ |
| Punto de ebullición |
459.1°C at 760 mmHg |
| Índice de refracción |
1.571 |
| Punto de inflamación |
195.4°C |
| Símbolos de Peligro |
 Xn:Harmful;
|
| Códigos de Riesgos |
R20/21/22:;
R40:;
|
| Descripción de Seguridad |
S22:;
S36:;
|
|
